Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Improvement of cognitive dysfunction by a novel phosphodiesterase type 5 inhibitor, Tadalafil

Published:2022-10-12 Issue:2 Volume:37 Page:263-274
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Otari Kishor Vasant¹^ORCID,Patil Rupesh J.²,Upasani Chandrashekhar Devidas³

Affiliation:

1. Department of Pharmacology Navsahyadri Institute of Pharmacy Naigaon (Nasrapur), Tal. Bhor, Dist. Pune India

2. Navsahyadri Group of Institutes Naigaon (Nasrapur), Tal. Bhor, Dist. Pune India

3. Department of Pharmacology SNJB's SSJ College of Pharmacy Neminagar, Chandwad, Dist. Nashik India

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12840

Reference57 articles.

1. Effect of an NMDA receptor agonist on T‐maze and passive avoidance test in 12‐week streptozotocin‐induced diabetic rats;Grzeda E;Pharmacol Rep,2007

2. The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging

3. Phosphodiesterases in the Central Nervous System: Implications in Mood and Cognitive Disorders

4. Improving Memory: A Role for Phosphodiesterases

5. Phosphodiesterase type 5 (PDE5) inhibition and cognitive enhancement

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP